Novartis AG
Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof
Last updated:
Abstract:
Provided herein are formulations, processes, solid forms and methods of use relating to (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-- ethylbenzyl)azetidine-3-carboxylic acid.
Status:
Application
Type:
Utility
Filling date:
24 Jan 2020
Issue date:
24 Dec 2020